Literature DB >> 10887655

Involvement of the mitogen-activated protein (MAP) kinase signalling pathway in host cell invasion by Toxoplasma gondii.

F Robert-Gangneux1, C Creuzet, J Dupouy-Camet, M P Roisin.   

Abstract

Little is known about signalling in Toxoplasma gondii, but it is likely that protein kinases might play a key role in the parasite proliferation, differentiation and probably invasion. We previously characterized Mitogen-Activated Protein (MAP) kinases in T. gondii lysates. In this study, cultured cells were tested for their susceptibility to Toxoplasma gondii infection after tachyzoite pretreatment with drugs interfering with MAP kinase activation pathways. Protein kinases inhibitors, i.e. genistein, RO31-8220 and PD098059, reduced tachyzoite infectivity by 38 +/- 4.5%, 85.5 +/- 9% and 56 +/- 10%, respectively. Conversely, protein kinases activators, i.e. bombesin and PMA, markedly increased infectivity (by 202 +/- 37% and 258 +/- 14%, respectively). These results suggest that signalling pathways involving PKC and MAP kinases play a role in host cell invasion by Toxoplasma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887655     DOI: 10.1051/parasite/2000072095

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  9 in total

1.  Involvement of MAPK activation in chemokine or COX-2 productions by Toxoplasma gondii.

Authors:  Ji-Young Kim; Myoung-Hee Ahn; Hyun-Ouk Song; Jong-Hak Choi; Jae-Sook Ryu; Duk-Young Min; Myung-Hwan Cho
Journal:  Korean J Parasitol       Date:  2006-09       Impact factor: 1.341

2.  Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells.

Authors:  Jae-Ho Chang; Ju-Youn Park; Soo-Ki Kim
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

3.  The p38 MAPK inhibitor, SB203580, inhibits cell invasion by Neospora caninum.

Authors:  Xiaoxia Jin; Pengtao Gong; Guojiang Li; Xichen Zhang; Jianhua Li
Journal:  Parasitol Res       Date:  2016-12-30       Impact factor: 2.289

4.  Activity of isoflavone biochanin A in chronic experimental toxoplasmosis: impact on inflammation.

Authors:  Wafaa A Aboukamar; Abeer A Elhenawy; Manar S Elmehankar; Manal A Elzoheiry; Randa El-Gamal; Lamiaa M Elabbasy; Heba Hany; Nairmen Nabih
Journal:  Parasitol Res       Date:  2022-06-17       Impact factor: 2.383

Review 5.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

6.  Reduced parasite motility and micronemal protein secretion by a p38 MAPK inhibitor leads to a severe impairment of cell invasion by the apicomplexan parasite Eimeria tenella.

Authors:  Françoise I Bussière; Fabien Brossier; Yves Le Vern; Alisson Niepceron; Anne Silvestre; Thibaut de Sablet; Sonia Lacroix-Lamandé; Fabrice Laurent
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

7.  Infectivity of Leishmania mexicana is associated with differential expression of protein kinase C-like triggered during a cell-cell contact.

Authors:  Nidia Alvarez-Rueda; Marlène Biron; Patrice Le Pape
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

8.  Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.

Authors:  Yongmei Han; Oluyomi Stephen Adeyemi; Mohammad Hazzaz Bin Kabir; Kentaro Kato
Journal:  Parasitol Res       Date:  2020-04-01       Impact factor: 2.289

9.  Gga-miR-3525 Targets PDLIM3 through the MAPK Signaling Pathway to Regulate the Proliferation and Differentiation of Skeletal Muscle Satellite Cells.

Authors:  Huadong Yin; Jing Zhao; Haorong He; Yuqi Chen; Yan Wang; Diyan Li; Qing Zhu
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.